openPR Logo
Press release

Harvard Doctor Ashok Bharucha Collaborates with Ibogaine by David Dardashti to Optimize Treatment for Depression and Trauma

06-17-2024 06:26 PM CET | IT, New Media & Software

Press release from: ABNewswire

Harvard Doctor Ashok Bharucha Collaborates with Ibogaine

Ibogaine by David Dardashti, a leading provider of innovative ibogaine treatments, is proud to announce agroundbreaking collaboration with renowned Harvard Medical School doctor, Ashok Bharucha, M.D. The partnership aims to revolutionize the use of ibogaine in addressing depression and trauma by developing a novel approach to personalize treatment protocols based on psychological assessments.

Dr. Bharucha, a distinguished expert in psychopharmacology and neuropsychopharmacology, will lend his expertise to Ibogaine by David Dardashti's ongoing research and development efforts. The collaboration will focus on creating a standardized psychological assessment tool that can accurately measure the severity of depression and trauma in individual patients. This assessment tool will serve as the foundation for a personalized treatment plan tailored to each patient's unique needs.

"We are thrilled to be working with Dr. Bharucha, a true pioneer in the field of mental health," said David Dardashti, Founder of Ibogaine by David Dardashti. "His expertise will be invaluable as we strive to optimize our ibogaine treatment protocols and provide the most effective care possible for our patients struggling with depression and trauma."

The personalized treatment plans developed through this collaboration will utilize a scoring system based on the results of the psychological assessments. The scoring system will guide the administration of ibogaine, ensuring that each patient receives the appropriate dosage and duration of treatment. This individualized approach will maximize the therapeutic benefits of ibogaine while minimizing the risk of adverse reactions.

Ibogaine by David Dardashti is committed to advancing the field of ibogaine therapy through research, education, and clinical innovation. The partnership with Dr. Bharucha represents a significant step forward in this mission, as it promises to transform the way ibogaine is used to address depression and trauma.

About Ibogaine by David Dardashti

Ibogaine by David Dardashti is a leading provider of ibogaine treatments, dedicated to helping individuals overcome addiction and trauma. With a focus on research, education, and clinical innovation, the organization is committed to advancing the field of ibogaine therapy and providing the most effective care possible for its patients.

Media Contact
Company Name: Ibogaine By David Dardashti
Contact Person: Cole Barressi
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=harvard-doctor-ashok-bharucha-collaborates-with-ibogaine-by-david-dardashti-to-optimize-treatment-for-depression-and-trauma]
Country: United States
Website: http://www.ibogaineclinic.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Harvard Doctor Ashok Bharucha Collaborates with Ibogaine by David Dardashti to Optimize Treatment for Depression and Trauma here

News-ID: 3541879 • Views:

More Releases from ABNewswire

What are the most effective medical therapies for managing excess body mass? Regenerative Medicine Advances Transform Cape Coral Weight Management Programs
What are the most effective medical therapies for managing excess body mass? Reg …
Cape Coral healthcare providers report breakthrough success using FDA-approved GLP-1 medications for weight management, with Premier Wellness Florida leading comprehensive treatment programs combining pharmaceuticals with holistic wellness support. Cape Coral, FL - Recent clinical developments in medical weight management have prompted Southwest Florida healthcare providers to report significant patient success rates with FDA-approved medications and comprehensive treatment protocols. Premier Wellness Florida, operating from its Del Prado Boulevard facility, has documented patient
Winkler Kurtz LLP - Long Island Lawyers Port Jefferson Station Injury Attorney Offering Trusted Legal Support
Winkler Kurtz LLP - Long Island Lawyers Port Jefferson Station Injury Attorney O …
Winkler Kurtz LLP is a leading Long Island law firm specializing in personal injury cases such as car accidents, slip and falls, and medical malpractice. Offering decades of local experience, the firm provides compassionate support and skilled legal advocacy to help injury victims secure justice and compensation. With free consultations and a contingency fee policy, Winkler Kurtz LLP ensures quality legal help is available to all Long Islanders in need. When
How to Pick the Best Online Chemistry Tutoring Platform
How to Pick the Best Online Chemistry Tutoring Platform
Image: https://www.abnewswire.com/upload/2025/10/814f4b38d9855ce5fcc0509bfebaa240.jpg Choosing the right chemistry tutoring platform can make the difference between academic success and continued struggles with complex reactions and molecular structures. With students increasingly turning to digital solutions for personalized learning support, the online chemistry tutoring market has exploded with options promising everything from AI-powered progress tracking to virtual lab experiences that transform how learners approach this challenging subject. Essential Platform Features for Effective Online Chemistry Tutoring Modern chemistry tutoring
Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Chronic Myeloid Leukemia Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Chronic Myeloid Leukemia pipeline landscape. It covers the Chronic Myeloid Leukemia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Myeloid Leukemia Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Curious

All 5 Releases


More Releases for Ibogaine

Ibogaine by David Dardashti to Illuminate the Transformative Ibogaine Experience …
DENVER, CO - June 20, 2024 - Ibogaine by David Dardashti, a pioneer in holistic Ibogaine therapy, is proud to announce its prominent participation on Day 2 of the highly anticipated Psychedelic Conference 2025. David Dardashti and his team will offer individual descriptions of the unique Ibogaine experience, providing invaluable insights for each and every person at the conference seeking information regarding profound and lasting healing from addiction, trauma, and
Ibogaine By David Dardashti is Pioneering Brain Wave Research in Ibogaine Treatm …
Renowned ibogaine expert David Dardashti is embarking on groundbreaking research measuring brain wave activity before and after ibogaine treatment. This study aims to shed light on ibogaine's impact on brain function and its potential to promote a more balanced and fulfilling life. Brain waves are electrical impulses that are produced by the brain and can be measured using an electroencephalogram (EEG). There are four main types of brain waves: alpha, beta,
Ibogaine By David Dardashti Initiates Ibogaine Data Storage on Google Cloud
Ibogaine By David Dardashti a leading psychedelic treatment center, today announced the commencement of ibogaine patient data storage and analysis on the Google Cloud platform. This initiative aims to leverage machine learning to enhance the precision and safety of ibogaine dosing based on past patient outcomes. Ibogaine, a naturally occurring psychoactive substance, has shown promise in treating opioid addiction and other mental health conditions. However, its administration requires careful dosing due
Ibogaine by David Dardashti Offers Proprietary Software to Accelerate Ibogaine R …
Ibogaine by David Dardashti, a renowned pioneer in ibogaine treatment and research, has recently made an exciting announcement regarding the availability of its proprietary software. This software is being offered to contribute to the donations made by Google co-founder towards ibogaine research specifically focused on traumatic brain injury. This potential for collaboration between Ibogaine by David Dardashti and Google co-founder's donations signifies a significant step forward in the field of ibogaine
Ibogaine By David Dardashti's Ibogaine Therapy Revolutionized by Questineers' SQ …
Ibogaine By David Dardashti, a leading innovator in the field of ibogaine therapy, today announced a groundbreaking advancement in the optimization of his ibogaine treatment software. Dardashti's software has revolutionized the way patient data is analyzed by utilizing the power of SQL. Instead of manually sifting through mountains of data, healthcare providers can now simply ask the software specific questions to extract the information they need. This streamlined approach not only
Ibogaine By David Dardashti Incorporates SQL into Ibogaine Software for Enhanced …
Ibogaine By David Dardashti, a leading provider of innovative solutions in the field of ibogaine therapy, today announced the integration of SQL (Structured Query Language) into its proprietary ibogaine software. This development marks a significant step forward in leveraging the power of data analysis to optimize the ibogaine algorithm for enhanced treatment outcomes With the integration of SQL, Ibogaine By David Dardashti has significantly enhanced its ability to analyze a vast